Functional gastroduodenal disorders.
Jan Tack, Nicholas J Talley, Michael Camilleri...
https://pubmed.ncbi.nlm.nih.gov/16678560Actively Recruiting
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-01
30
Participants Needed
1
Research Sites
6 weeks
Total Duration
Researchers are studying the effects of a low-FODMAP diet on patients with functional dyspepsia (FD), a condition causing upper digestive symptoms like fullness, pain, and burning without an obvious organic cause. The study aims to see if this diet can reduce these symptoms and understand how it might work, focusing on duodenal changes and urinary histamine levels related to FD. Functional dyspepsia is common and can significantly impact daily life and healthcare costs, especially in patients with severe symptoms and psychosocial effects. Participants will follow a structured dietary plan starting with a 2-week baseline period, followed by 6 weeks on a strict low-FODMAP diet. Next, a 5-week single-blind reintroduction phase tests individual FODMAP groups and a control substance. Finally, a 2-week moderate FODMAP diet phase allows consumption of non-triggering FODMAPs. The study provides educational materials and recipes to support diet adherence. Urine samples and duodenal biopsies are collected before and after the strict diet to examine physiological changes. During the study, participants will have symptom assessments using the Leuven-postprandial distress scale before and after the diet. Researchers will measure urinary histamine, N-methylhistamine, duodenal mucosal integrity, and low-grade inflammation to explore diet effects. Endoscopies and 24-hour urine collections occur at baseline and after six weeks. The total participation includes about 15 weeks of dietary phases and monitoring, allowing detailed evaluation of symptom changes and biological responses.
CONDITIONS
Low FODMAP Diet in FD (PDS)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 weeks
Participants follow a 2-week baseline period to establish symptom and urinary histamine levels before starting the diet.
Visits as needed for baseline measurements
Duration - 6 weeks
Participants follow a 6-week strict low FODMAP diet to evaluate its effect on gastrointestinal symptoms and urinary histamine excretion.
Regular visits for diet support and assessments
Duration - 5 weeks
Participants undergo a 5-week single-blind reintroduction phase where different FODMAP groups are challenged sequentially to identify symptom triggers.
Several visits or check-ins for symptom monitoring during challenges
Duration - 2 weeks
Participants follow a 2-week moderate FODMAP diet based on tolerated foods identified during reintroduction.
Visits or contacts for final assessments
Total: 1 location
1
KU Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jan Tack, Nicholas J Talley, Michael Camilleri...
https://pubmed.ncbi.nlm.nih.gov/16678560B E Lacy, K T Weiser, A T Kennedy...
https://pubmed.ncbi.nlm.nih.gov/23725230H Piessevaux, B De Winter, E Louis...
https://pubmed.ncbi.nlm.nih.gov/19222761N J Talley, M Verlinden, M Jones
https://pubmed.ncbi.nlm.nih.gov/10483997H B El-Serag, N J Talley
https://pubmed.ncbi.nlm.nih.gov/12940923Michael P Jones, Nicholas J Talley, Guy D Eslick...
https://pubmed.ncbi.nlm.nih.gov/18796099P Aro, N J Talley, L Agréus...
https://pubmed.ncbi.nlm.nih.gov/21443537J Tack, H Piessevaux, B Coulie...
https://pubmed.ncbi.nlm.nih.gov/9834261Florencia Carbone, Jan Tack, Ilse Hoffman
https://pubmed.ncbi.nlm.nih.gov/27557427P Janssen, S Verschueren, H Giao Ly...
https://pubmed.ncbi.nlm.nih.gov/21299720